These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34743250)

  • 1. Fractal analysis of
    Maeda Y; Yamamoto Y; Norikane T; Mitamura K; Hatakeyama T; Miyake K; Nishiyama Y; Kudomi N
    EJNMMI Phys; 2021 Nov; 8(1):76. PubMed ID: 34743250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of PET/CT with
    Ogawa T; Kawai N; Miyake K; Shinomiya A; Yamamoto Y; Nishiyama Y; Tamiya T
    EJNMMI Res; 2020 May; 10(1):44. PubMed ID: 32382870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake.
    Tanaka K; Yamamoto Y; Maeda Y; Yamamoto H; Kudomi N; Kawai N; Toyohara J; Nishiyama Y
    Ann Nucl Med; 2016 Feb; 30(2):89-96. PubMed ID: 26511019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-evaluation of the diagnostic performance of
    Kim D; Chun JH; Kim SH; Moon JH; Kang SG; Chang JH; Yun M
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1678-1684. PubMed ID: 31102001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of volume-based measurements on (11)C-methionine PET in glioma patients.
    Kobayashi K; Hirata K; Yamaguchi S; Manabe O; Terasaka S; Kobayashi H; Shiga T; Hattori N; Tanaka S; Kuge Y; Tamaki N
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1071-80. PubMed ID: 25852010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Pretreatment
    Kaneko K; Koriyama S; Tsuzuki S; Masui K; Kanasaki R; Yamamoto A; Nagao M; Muragaki Y; Kawamata T; Sakai S
    World Neurosurg; 2024 Jun; 186():e495-e505. PubMed ID: 38583563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma.
    Hatakeyama T; Kawai N; Nishiyama Y; Yamamoto Y; Sasakawa Y; Ichikawa T; Tamiya T
    Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2009-17. PubMed ID: 18542957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11 C-Acetate PET/CT for Reactive Astrogliosis Outperforms 11 C-Methionine PET/CT in Glioma Classification and Survival Prediction.
    Kim D; Yi JH; Park Y; Kim SJ; Kang SG; Kim SH; Chun JH; Chang JH; Yun M
    Clin Nucl Med; 2024 Feb; 49(2):109-115. PubMed ID: 38049976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma.
    Lopci E; Riva M; Olivari L; Raneri F; Soffietti R; Piccardo A; Bizzi A; Navarria P; Ascolese AM; Rudà R; Fernandes B; Pessina F; Grimaldi M; Simonelli M; Rossi M; Alfieri T; Zucali PA; Scorsetti M; Bello L; Chiti A
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1155-1164. PubMed ID: 28110346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Performance of [
    Nakajo K; Uda T; Kawashima T; Terakawa Y; Ishibashi K; Tsuyuguchi N; Tanoue Y; Nagahama A; Uda H; Koh S; Sasaki T; Ohata K; Kanemura Y; Goto T
    World Neurosurg; 2021 Apr; 148():e471-e481. PubMed ID: 33444827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas.
    Torii K; Tsuyuguchi N; Kawabe J; Sunada I; Hara M; Shiomi S
    Ann Nucl Med; 2005 Dec; 19(8):677-83. PubMed ID: 16444993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Nomogram Modeling
    Zhou W; Zhou Z; Wen J; Xie F; Zhu Y; Zhang Z; Xiao J; Chen Y; Li M; Guan Y; Hua T
    Front Oncol; 2020; 10():1200. PubMed ID: 32850348
    [No Abstract]   [Full Text] [Related]  

  • 13. The Relationship Between IDH1 Mutation Status and Metabolic Imaging in Nonenhancing Supratentorial Diffuse Gliomas: A
    Kudulaiti N; Zhang H; Qiu T; Lu J; Aibaidula A; Zhang Z; Guan Y; Zhuang D
    Mol Imaging; 2019; 18():1536012119894087. PubMed ID: 31889470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia and glucose metabolism assessed by FMISO and FDG PET for predicting IDH1 mutation and 1p/19q codeletion status in newly diagnosed malignant gliomas.
    Suzuki K; Kawai N; Ogawa T; Miyake K; Shinomiya A; Yamamoto Y; Nishiyama Y; Tamiya T
    EJNMMI Res; 2021 Jul; 11(1):67. PubMed ID: 34291337
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Zhao X; Li D; Qiao Z; Wang K; Chen Q; Pan C; Wu Y; Xiao D; Xi T; Zhang L; Ai L
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1709-1719. PubMed ID: 36697961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATRX status correlates with 11 C-methionine uptake in WHO grade II and III gliomas with IDH1 mutations.
    Ogishima T; Tamura K; Kobayashi D; Inaji M; Hayashi S; Tamura R; Nariai T; Ishii K; Maehara T
    Brain Tumor Pathol; 2017 Jan; 34(1):20-27. PubMed ID: 28251430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 11 C-Acetate PET/CT Detects Reactive Astrogliosis Helping Glioma Classification.
    Kim D; Chun JH; Yi JH; Ko HY; Chung JI; Lee M; Park YM; Nam MH; Kim J; Kim SY; Park Y; Moon JH; Kang SG; Chang JH; Lee CJ; Kim SH; Yun M
    Clin Nucl Med; 2022 Oct; 47(10):863-868. PubMed ID: 35868002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of traditional CHO PET parameters in distinguishing IDH, TERT and MGMT alterations in primary diffuse gliomas.
    Kong Z; Zhang Y; Liu D; Liu P; Shi Y; Wang Y; Zhao D; Cheng X; Wang Y; Ma W
    Ann Nucl Med; 2021 Apr; 35(4):493-503. PubMed ID: 33532992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas.
    Hartmann C; Hentschel B; Wick W; Capper D; Felsberg J; Simon M; Westphal M; Schackert G; Meyermann R; Pietsch T; Reifenberger G; Weller M; Loeffler M; von Deimling A
    Acta Neuropathol; 2010 Dec; 120(6):707-18. PubMed ID: 21088844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic value of lower glucose consumption for IDH1 mutated gliomas on FDG-PET.
    Liu FM; Gao YF; Kong Y; Guan Y; Zhang J; Li SH; Ye D; Wen W; Zuo C; Hua W
    BMC Cancer; 2021 Jan; 21(1):83. PubMed ID: 33472598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.